Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study

BACKGROUND: Immune checkpoint inhibitors (ICIs) foster anti-cancer immune responses. Their efficacy comes at the cost of immune-related adverse events (IRAEs). The latter affects various organs, including kidneys, mostly as acute tubulointerstitial nephritis, the pathophysiology of which remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gérard, Alexandre O, Barbosa, Susana, Parassol, Nadège, Andreani, Marine, Merino, Diane, Cremoni, Marion, Laurain, Audrey, Pinel, Sylvine, Bourneau-Martin, Delphine, Rocher, Fanny, Esnault, Vincent L M, Borchiellini, Delphine, Sicard, Antoine, Drici, Milou-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494514/
https://www.ncbi.nlm.nih.gov/pubmed/36158153
http://dx.doi.org/10.1093/ckj/sfac109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494514/
https://www.ncbi.nlm.nih.gov/pubmed/36158153
http://dx.doi.org/10.1093/ckj/sfac109

Ejemplares similares